113 related articles for article (PubMed ID: 7019575)
1. Stimulatory activity of PHA-LCM for normal human hemopoietic progenitors and leukemic blast cell precursors: separation by isoelectric focusing.
Fauser AA; Messner HA
J Supramol Struct Cell Biochem; 1981; 15(1):41-8. PubMed ID: 7019575
[TBL] [Abstract][Full Text] [Related]
2. Interference of a human leukocyte interferon preparation with stimulatory activities in leukocyte-conditioned medium for human hematopoietic stem cells.
Kanz L; Löhr GW; Fauser AA
Int J Cell Cloning; 1984 Sep; 2(5):286-95. PubMed ID: 6491391
[TBL] [Abstract][Full Text] [Related]
3. Response of human myeloid leukemia cells to various sources of colony-stimulating activity and phytohemagglutinin-conditioned medium.
Taetle R; Caviles A; Koziol J
Cancer Res; 1983 May; 43(5):2350-7. PubMed ID: 6600965
[TBL] [Abstract][Full Text] [Related]
4. Pluripotent hemopoietic progenitors (CFU-GEMM) in chronic myelogenous leukemia.
Lepine J; Messner HA
Int J Cell Cloning; 1983 Sep; 1(4):230-9. PubMed ID: 6583283
[TBL] [Abstract][Full Text] [Related]
5. Electrofocusing pattern of fucosyltransferase activity in human leukemic cells.
Suda K; Sakamoto S; Hida K; Kano Y; Takaku F; Miura Y
Cancer Res; 1987 Jun; 47(11):2782-6. PubMed ID: 3471318
[TBL] [Abstract][Full Text] [Related]
6. Stimulatory activities for human multilineage hemopoietic progenitors (CFU-GEMMT) derived from patients with hemochromatosis and from normal volunteers.
Wahnschaffe A; Löhr GW; Neumann HA; Fauser AA
Exp Hematol; 1984 Sep; 12(8):655-9. PubMed ID: 6333352
[TBL] [Abstract][Full Text] [Related]
7. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia.
Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
Exp Hematol; 1997 Mar; 25(3):199-204. PubMed ID: 9091294
[TBL] [Abstract][Full Text] [Related]
8. The cellular basis of self renewal in culture by human acute myeloblastic leukemia blast cell progenitors.
Chang LJ; Till JE; McCulloch EA
J Cell Physiol; 1980 Feb; 102(2):217-22. PubMed ID: 6929277
[TBL] [Abstract][Full Text] [Related]
9. A new method for colony formation in vitro by leukemic cells in acute nonlymphocytic leukemia with PHA-stimulated lymphocyte conditioned medium as stimulating factor.
Moriyama Y; Koike T; Takahashi M; Sakurai K; Fujiwara M; Takai K; Kishi K; Sakai C; Sanada M; Shibata A
Stem Cells (1981); 1982; 2(4):189-202. PubMed ID: 6963001
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of haemopoietic stem cell adherence to bone-marrow derived stroma by phyto-haemagglutinin treated leucocyte conditioned medium (PHA-LCM).
Desai SS; Goud AP; Tendolkar AG; Rao SG
Indian J Exp Biol; 1994 Apr; 32(4):225-8. PubMed ID: 8088878
[TBL] [Abstract][Full Text] [Related]
11. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
12. Properties of human pluripotent hemopoietic progenitors.
Messner HA; Fauser AA; Lepine J; Martin M
Blood Cells; 1980; 6(4):595-607. PubMed ID: 6937220
[TBL] [Abstract][Full Text] [Related]
13. [Selective photodynamic destruction of leukemic cells].
Hrkal Z; Cajthamlová H; Grebenová D; Bartosová J; Klamová H; Marinov J
Cas Lek Cesk; 2000 Mar; 139(5):148-54. PubMed ID: 10838736
[TBL] [Abstract][Full Text] [Related]
14. Characterization of stimulatory activity for human pluripotent stem cells (CFUGEMM).
Ruppert S; Löhr GW; Fauser AA
Exp Hematol; 1983 Feb; 11(2):154-61. PubMed ID: 6601024
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
16. [The role of cytokines in the proliferation of leukemia cells in acute myelogenous leukemia].
Nara N
Rinsho Byori; 1993 Dec; 41(12):1289-95. PubMed ID: 7507532
[TBL] [Abstract][Full Text] [Related]
17. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
18. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
Novitzky N; Mohamed R
Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
[TBL] [Abstract][Full Text] [Related]
19. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
[TBL] [Abstract][Full Text] [Related]
20. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
Lu L; Xiao M; Li ZH; Jolliffe LK; Jones S; Broxmeyer HE; Weich N
Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
